RESUMEN
Non-pigmented rapidly growing mycobacteria (NPRGM) are widely distributed in water, soil and animals. It has been observed an increasing importance of NPRGM related-infections, particularly due to the high antimicrobial resistance. NPRGM have rough and smooth colony phenotypes, and several studies have showed that rough colony variants are more virulent than smooth ones. However, other studies have failed to validate this observation. In this study, we have performed two models, invitro and in vivo, in order to assess the different pathogenicity of these two phenotypes. We used collection and clinical strains of Mycobacteriumabscessus, Mycobacterium fortuitum and Mycobacteriumchelonae. On the invitro model (macrophages), phagocytosis was higher for M. abscessus and M. fortuitum rough colony variant strains when compared to smooth colony variants. However, we did not find differences with colonial variants of M. chelonae. Survival of Galleriamellonella larvae in the experimental model was lower for M. abscessus and M. fortuitum rough colony variants when compared with larvae infected with smooth colony variants. We did not find differences in larvae infected with M. chelonae.Results of our in vivo study correlated well with the experimental model. This fact could have implications on the interpretation of the clinical significance of the NPRGM isolate colonial variants.
Asunto(s)
Infecciones por Mycobacterium no Tuberculosas/microbiología , Infecciones por Mycobacterium no Tuberculosas/patología , Mycobacterium abscessus/patogenicidad , Mycobacterium chelonae/patogenicidad , Mycobacterium fortuitum/patogenicidad , Fenotipo , Animales , Modelos Animales de Enfermedad , Larva , Lepidópteros , Macrófagos/inmunología , Macrófagos/microbiología , Modelos Teóricos , Mycobacterium abscessus/crecimiento & desarrollo , Mycobacterium chelonae/crecimiento & desarrollo , Mycobacterium fortuitum/crecimiento & desarrollo , Fagocitosis , Pigmentos Biológicos/análisis , Análisis de Supervivencia , VirulenciaRESUMEN
Infections with rapidly growing mycobacteria are rare and most often seen in immunocompromised patients. We herein present the case of a 69-year-old man with a T-cell lymphoma treated by chemotherapy and mogamulizumab with a 6-month history of febrile episodes and subcutaneous nodules in both arms and arthritis of metacarpophalangeal joints. Blood cultures and DNA sequencing results demonstrated the growth of Mycobacterium chelonae. The patient was successfully treated with clarithromycin, moxifloxacin, and tobramycin, but died shortly after due to lymphoma progression.
Asunto(s)
Linfoma de Células T/complicaciones , Mycobacterium chelonae/crecimiento & desarrollo , Anciano , Humanos , Masculino , Mycobacterium chelonae/patogenicidadRESUMEN
Nontuberculous mycobacteria (NTM) are emergent pathogens whose importance in human health has been gaining relevance after being recognized as etiological agents of opportunist infections in HIV patients. Currently, NTM are recognized as etiological agents of several respiratory and extra-respiratory infections of immune-competent individuals. The environmental nature of NTM together with the ability to assemble biofilms on different surfaces plays a key role on their pathogenesis. In the present work the ability of three fast-growing NTM (Mycobacterium smegmatis, Mycobacterium fortuitum and Mycobacterium chelonae) to persist within a model of human alveolar macrophages was evaluated. Most often human infections with NTM occur by contact with the environment. Biofilms can work as environmental reservoirs. For this reason, it was decided to evaluate the ability of NTM to assemble biofilms on different surfaces. Scanning electron microscopy was used to elucidate the biofilm structure. The ability to assemble biofilms was connected with the ability to spread on solid media known as sliding. Biofilm assembly and intracellular persistence seems to be ruled by different mechanisms.
Asunto(s)
Adhesión Bacteriana , Macrófagos Alveolares/microbiología , Micobacterias no Tuberculosas/fisiología , Micobacterias no Tuberculosas/patogenicidad , Biopelículas , Línea Celular , Humanos , Macrófagos Alveolares/citología , Microscopía Electrónica de Rastreo , Infecciones por Mycobacterium no Tuberculosas/microbiología , Mycobacterium chelonae/patogenicidad , Mycobacterium chelonae/fisiología , Mycobacterium fortuitum/patogenicidad , Mycobacterium fortuitum/fisiología , Mycobacterium smegmatis/patogenicidad , Mycobacterium smegmatis/fisiologíaRESUMEN
Almost any species of non tuberculosis mycobacterium [NTM], including M. chelonae may be associated with nosocomial infections including catheter related sepsis, pneumonia etc. We present a case of catheter related sepsis due to M. chelonae which was treated with appropriate therapy including removal of the catheter. This case serves as a reminder to include the NTM group in the differential diagnosis of these nosocomial infections.
Asunto(s)
Infecciones Relacionadas con Catéteres/microbiología , Infección Hospitalaria/microbiología , Huésped Inmunocomprometido , Infecciones por Mycobacterium no Tuberculosas/microbiología , Mycobacterium chelonae/aislamiento & purificación , Mycobacterium chelonae/patogenicidad , Dispositivos de Acceso Vascular/microbiología , Adulto , Infecciones Relacionadas con Catéteres/diagnóstico , Infecciones Relacionadas con Catéteres/tratamiento farmacológico , Ciprofloxacina/uso terapéutico , Claritromicina/uso terapéutico , Infección Hospitalaria/diagnóstico , Infección Hospitalaria/tratamiento farmacológico , Quimioterapia Combinada , Femenino , Humanos , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Neoplasias Ováricas/complicaciones , Neoplasias Ováricas/terapia , Sepsis/tratamiento farmacológico , Sepsis/microbiologíaRESUMEN
La hidradenitis ecrina neutrofílica (HEN) es un patrón de reacción clínico-patológico inespecífico, que se ha clasificado como una dermatosis neutrofílica. Normalmente se ha descrito asociada a una enfermedad hematológica maligna. En algunas ocasiones se ha publicado la hidradenitis ecrina neutrofílica asociada a un microorganismo como Serratia, Enterobacter, Staphylococcus y VIH.Nosotros describimos 3 casos de hidradenitis ecrina infecciosa secundarias a infecciones por Nocardia, Mycobacterium chelonae y Staphylococcus aureus. Las biopsias mostraron un denso infiltrado perivascular y periductal de neutrófilos en la dermis. En las glándulas ecrinas se apreciaba degeneración vacuolar y necrosis de las células epiteliales, predominantemente en la porción secretora. Nuestros casos apoyan que la HEN es una respuesta cutánea característica a un estímulo inespecífico. Los hallazgos clínicos e histopatológicos de la HEN infecciosa o no infecciosa son generalmente indistinguibles. Cuando se considera un caso de HEN se debería investigar la posibilidad de una causa infecciosa y realizar un cultivo. En este artículo hemos revisado los diagnósticos diferenciales clínicos e histopatológicos y la literatura publicada de esta entidad (AU)
Neutrophilic eccrine hidradenitis (NEH) is a nonspecific clinicopathological reaction pattern, classified as a neutrophilic dermatosis, that usually develops in patients receiving chemotherapy for a hematologic malignancy. More rarely, it has been reported in association with infectious agents such as Serratia and Enterobacter species, Staphylococcus aureus, and human immunodeficiency virus. We describe 3 cases of infectious eccrine hidradenitis secondary to infection with Nocardia species, Mycobacterium chelonae, and S aureus. Histological findings revealed a dense infiltrate with perivascular and periductal neutrophils in the dermis. In the eccrine glands, there was vacuolar degeneration and necrosis of the epithelial cells. Our cases support the assertion that NEH is a characteristic cutaneous response to non specific stimuli. Clinical and histopathological findings of infectious and noninfectious NEH are generally indistinguishable and when NEH is suspected, the possibility of an infectious association must be investigated by skin tissue culture. In this article we also discuss differential diagnoses and review the literature (AU)
Asunto(s)
Humanos , Hidradenitis Supurativa/diagnóstico , Infecciones/complicaciones , Enfermedades Hematológicas/complicaciones , Factores de Riesgo , Nocardia/patogenicidad , Staphylococcus aureus/patogenicidad , Mycobacterium chelonae/patogenicidadAsunto(s)
Humanos , Masculino , Femenino , Adulto , Mycobacterium chelonae/aislamiento & purificación , Mycobacterium chelonae/patogenicidad , Tatuaje/tendencias , Biopsia , Claritromicina/uso terapéutico , Infecciones/inducido químicamente , Infecciones/complicaciones , Tatuaje/efectos adversos , Tatuaje , Biopsia/métodos , Control de Infecciones/tendenciasAsunto(s)
Humanos , Masculino , Femenino , Mycobacterium chelonae/citología , Mycobacterium chelonae , Infecciones por Mycobacterium no Tuberculosas/etiología , Infecciones por Mycobacterium no Tuberculosas/microbiología , Infecciones por Mycobacterium no Tuberculosas/patología , Infecciones Bacterianas/diagnóstico , Infecciones Bacterianas/tratamiento farmacológico , Infecciones por Mycobacterium/diagnóstico , Anticuerpos Monoclonales/uso terapéutico , Infecciones por Mycobacterium no Tuberculosas/fisiopatología , Mycobacterium chelonae/fisiología , Mycobacterium chelonae/patogenicidad , Mycobacterium chelonae/inmunología , Infecciones Bacterianas/fisiopatología , Infecciones por Mycobacterium/tratamiento farmacológicoRESUMEN
Mycobacteriosis, a chronic bacterial infection, has been associated with severe losses in some zebrafish facilities and low-level mortalities and unknown impacts in others. The occurrence of at least six different described species (Mycobacterium abscessus, M. chelonae, M. fortuitum, M. haemophilum, M. marinum, M. peregrinum) from zebrafish complicates diagnosis and control because each species is unique. As a generalization, mycobacteria are often considered opportunists, but M. haemophilum and M. marinum appear to be more virulent. Background genetics of zebrafish and environmental conditions influence the susceptibility of fish and progression of disease, emphasizing the importance of regular monitoring and good husbandry practices. A combined approach to diagnostics is ultimately the most informative, with histology as a first-level screen, polymerase chain reaction for rapid detection and species identification, and culture for strain differentiation. Occurrence of identical strains of Mycobacterium in both fish and biofilms in zebrafish systems suggests transmission can occur when fish feed on infected tissues or tank detritus containing mycobacteria. Within a facility, good husbandry practices and sentinel programs are essential for minimizing the impacts of mycobacteria. In addition, quarantine and screening of animals coming into a facility is important for eliminating the introduction of the more severe pathogens. Elimination of mycobacteria from an aquatic system is likely not feasible because these species readily establish biofilms on surfaces even in extremely low nutrient conditions. Risks associated with each commonly encountered species need to be identified and informed management plans developed. Basic research on the growth characteristics, disinfection, and pathogenesis of zebrafish mycobacteria is critical moving forward.
Asunto(s)
Mycobacterium/patogenicidad , Pez Cebra/microbiología , Animales , Biopelículas/crecimiento & desarrollo , Enfermedades de los Peces/microbiología , Enfermedades de los Peces/prevención & control , Infecciones por Mycobacterium/diagnóstico , Infecciones por Mycobacterium/prevención & control , Mycobacterium chelonae/patogenicidadAsunto(s)
Oftalmopatías/veterinaria , Enfermedades de los Peces/patología , Infecciones por Mycobacterium no Tuberculosas/veterinaria , Animales , Ojo/patología , Enfermedades de los Peces/microbiología , Peces , Infecciones por Mycobacterium no Tuberculosas/patología , Mycobacterium chelonae/patogenicidad , Mycobacterium chelonae/fisiología , Factores de Virulencia/metabolismoRESUMEN
Mycobacterium chelonae es una micobacteria atípica, de rápido crecimiento, ampliamente distribuida en la naturaleza. Germen oportunista del humano y causante de infecciones de diversa gravedad. Suele ser resistente a los métodos habituales de desinfección y esterilización. Es fundamentalpara su diagnóstico y tratamiento el aislamiento del mismo y la obtención del antibiograma, ya que presenta resistencia a diferentes antibióticos. Se presentan dos casos clínicos de infección cutánea por Mycobacterium chelonae. El primero, un paciente inmunocompetente, con aislamiento de la micobacteria por punción-aspiración de las lesiones; tratado con antibióticos según antibiograma, con curación de las mismas. El segundo, una paciente inmunocomprometida no HIV, quien fue tratada con múltiples esquemas antibióticos, criocirugía, termoterapia y resección quirúrgica de las lesiones, con respuesta parcial. El presente artículo intenta actualizar conceptos sobre esta micobacteria y sus diferentes manifestaciones clínicas según el estado inmune del paciente que infecta.
Asunto(s)
Humanos , Masculino , Adulto , Femenino , Infecciones por Mycobacterium no Tuberculosas/etiología , Infecciones por Mycobacterium no Tuberculosas/patología , Mycobacterium chelonae/aislamiento & purificación , Mycobacterium chelonae/patogenicidad , Piel/microbiología , Piel/patología , Factores de RiesgoRESUMEN
No disponible
No disponible
Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Alveolitis Alérgica Extrínseca/diagnóstico , Alveolitis Alérgica Extrínseca/tratamiento farmacológico , Mycobacterium chelonae/aislamiento & purificación , Mycobacterium chelonae/patogenicidad , Claritromicina/uso terapéutico , Mycobacterium avium/aislamiento & purificación , Radiografía Torácica/métodos , Micobacterias no Tuberculosas/aislamiento & purificaciónRESUMEN
Atypical mycobacterial infections of the musculoskeletal system are very rare and are generally associated with predisposing factors, such as trauma, use of corticosteroids, or an immunocompromised state. There have only been three reports of Mycobacterium chelonae prosthetic infection of which two cases were associated with total hip arthroplasty and one with total knee arthroplasty and no reports of both Mycobacterium tuberculosis and M. chelonae occurring in the same joint. We report a case of a patient with rheumatoid arthritis treated with low-dose methotrexate (15 mg/week) who developed infection with both M. tuberculosis and M. chelonae after the revision of a prosthetic hip. Joint infections by mycobacteria are clinically indistinguishable from those caused by more common bacterial pathogens and, therefore, diagnosis is often delayed. Recurrent prosthetic hip infections, particularly in immunosuppressive patients, should alert the physician to consider the possibility of both tuberculous and atypical mycobacterial infections. Obtaining appropriate cultures can be critical in making the diagnosis and directing treatment. With the increasing use of immunosuppressive agents, including TNF alpha inhibitors, it is likely that there will be an increase in the number of mycobacterial infections complicating arthroplasties.
Asunto(s)
Artritis Reumatoide/tratamiento farmacológico , Prótesis de Cadera/microbiología , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Mycobacterium chelonae/patogenicidad , Mycobacterium tuberculosis/patogenicidad , Infecciones Oportunistas/diagnóstico , Tuberculosis/diagnóstico , Anciano , Antirreumáticos/efectos adversos , Antirreumáticos/uso terapéutico , Artritis Reumatoide/complicaciones , Artritis Reumatoide/cirugía , Humanos , Inmunosupresores/efectos adversos , Inmunosupresores/uso terapéutico , Masculino , Metotrexato/efectos adversos , Metotrexato/uso terapéutico , Infecciones por Mycobacterium no Tuberculosas/etiología , Infecciones Oportunistas/etiología , Tuberculosis/etiología , Factor de Necrosis Tumoral alfa/antagonistas & inhibidoresRESUMEN
We isolated a rough variant of Mycobacterium abscessus CIP 104536T during experimental infection of mice. We show that this variant has lost the ability to produce glycopeptidolipids, is hyperlethal for C57BL/6 mice infected intravenously, and induces a strong tumor necrosis factor-alpha response by murine monocyte-derived macrophages.
Asunto(s)
Infecciones por Mycobacterium no Tuberculosas/microbiología , Mycobacterium chelonae/patogenicidad , Animales , Modelos Animales de Enfermedad , Glucolípidos/biosíntesis , Glicopéptidos/biosíntesis , Macrófagos/inmunología , Ratones , Ratones Endogámicos C57BL , Mutación , Infecciones por Mycobacterium no Tuberculosas/inmunología , Mycobacterium chelonae/inmunología , Mycobacterium chelonae/fisiología , Análisis de Supervivencia , Factor de Necrosis Tumoral alfa/biosíntesis , VirulenciaRESUMEN
A series of 145 laparoscopy port site infections due to Mycobacterium chelonae were found in 35 patients following laparoscopy at a single hospital over a six-week period. The contaminating source was ultimately identified as the rinsing water used for washing chemically disinfected instruments. The organism survived and grew within the biofilm at the bottom of disinfectant trays and within the outer sleeves of re-usable laparoscopic instruments. Remedial control measures included changing to ethylene oxide gas sterilization of laparoscopic equipment instead of chemical sterilization, thorough dismantling and manual precleaning of instruments, drying prior to gas sterilization, and random checks of environmental samples within the operating room complex for acid-fast bacilli. No further atypical mycobacterial infective episodes have occurred in the three years since the study. Awareness of this ubiquitous opportunistic organism that is not easily eradicated from the hospital environment, careful surveillance, detailed attention to disinfection methods of medical devices, and appropriate control measures are essential to prevent potential outbreaks.
Asunto(s)
Infección Hospitalaria/microbiología , Brotes de Enfermedades , Laparoscopía/efectos adversos , Infecciones por Mycobacterium no Tuberculosas/etiología , Mycobacterium chelonae/patogenicidad , Instrumentos Quirúrgicos/microbiología , Infección de la Herida Quirúrgica/microbiología , Biopelículas/crecimiento & desarrollo , Descontaminación/instrumentación , Contaminación de Equipos , Femenino , Humanos , India , Masculino , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Infección de la Herida Quirúrgica/tratamiento farmacológico , Abastecimiento de Agua/análisisRESUMEN
No disponible
Asunto(s)
Femenino , Humanos , Mycobacterium chelonae/patogenicidad , Toxinas Botulínicas/efectos adversos , Infecciones por Mycobacterium no Tuberculosas/diagnóstico , Huésped Inmunocomprometido/inmunología , Enfermedades Cutáneas Bacterianas/microbiología , Infecciones por Mycobacterium no Tuberculosas/transmisiónRESUMEN
A previously healthy man working as a machine operator in an automotive factory developed respiratory symptoms. Medical evaluation showed abnormal pulmonary function tests, a lung biopsy showed hypersensitivity pneumonitis, and his illness was traced to his work environment. His physician asked the employer to remove him from exposure to metalworking fluids. Symptoms reoccurred when he was later reexposed to metalworking fluids, and further permanent decrement in his lung function occurred. Investigation of his workplace showed that five of six large reservoirs of metalworking fluids (cutting oils) grew Mycobacterium chelonae (or Mycobacterium immunogenum), an organism previously associated with outbreaks of hypersensitivity pneumonitis in automaking factories. His lung function remained stable after complete removal from exposure. The employer, metalworking fluid supplier, union, and the National Institute for Occupational Safety and Health were notified of this sentinel health event. No further cases have been documented in this workplace.
Asunto(s)
Alveolitis Alérgica Extrínseca/microbiología , Aceites Industriales/microbiología , Metalurgia , Infecciones por Mycobacterium no Tuberculosas/etiología , Enfermedades Profesionales/microbiología , Exposición Profesional , Humanos , Masculino , Persona de Mediana Edad , Mycobacterium chelonae/aislamiento & purificación , Mycobacterium chelonae/patogenicidad , Enfermedades Profesionales/diagnóstico , Pruebas de Función Respiratoria , Tomografía Computarizada por Rayos XAsunto(s)
Enfermedades Mandibulares/microbiología , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Mycobacterium chelonae/patogenicidad , Osteomielitis/microbiología , Adulto , Amicacina/uso terapéutico , Antibacterianos/uso terapéutico , Claritromicina/uso terapéutico , Farmacorresistencia Bacteriana , Femenino , Humanos , Infecciones por Mycobacterium no Tuberculosas/etiología , Infecciones por Mycobacterium no Tuberculosas/microbiología , Rifampin/uso terapéutico , Tratamiento del Conducto Radicular/efectos adversosRESUMEN
BACKGROUND & OBJECTIVE: The non-tuberculous mycobacteria (NTM) have emerged as important opportunistic pathogens of human beings in the recent years. The NTM are rapid growing mycobacteria (RGM), which include Mycobacterium fortuitum and M. chelonae and grouped as M. fortuitum-chelonae complex. Though there are reports on isolation of NTM from various parts of India, information on its occurrence in northeastern India is lacking. We therefore undertook this preliminary investigation to report on the occurrence of NTM-associated with non-healing postoperative wound infections that did not respond to antibiotics used for pyogenic infections and having sterile routine aerobic cultures in patients from northeastern part of India. METHODS: Pus/discharge from 25 patients with delayed onset of post-operative wound infections not responding to antibiotics used for pyogenic infections were collected and examined for isolation and identification of the causative agents. RESULTS: Of the 25 pus/discharge specimens examined, 20 revealed growth of non-tuberculous Mycobacterium spp. All the isolates were identified as M. fortuitum-chelonae complex. Of these only 10 samples revealed acid-fast bacilli (AFB) on direct examination of Ziehl-Neelsen stained smears from the specimens. All cases where direct smear was positive for AFB were also positive for Mycobacterium culture. INTERPRETATION & CONCLUSION: The results of the present study indicated that non-tuberculous mycobacterial post-operative wound infection was fairly common in northeastern India. Thus, mycobacterial infections should be considered in wounds that show delayed healing and do not respond to antibiotics used for acute pyogenic infections. Further, 80 per cent of the specimens yielded the growth of AFB in cultures as against only 40 per cent positive in the ZN stained direct smears. This indicates the possibility of missing a mycobacterial wound infection if only direct smears are taken for diagnosis.
Asunto(s)
Infecciones por Mycobacterium no Tuberculosas/etiología , Infección de la Herida Quirúrgica/etiología , Adulto , Femenino , Humanos , India , Masculino , Persona de Mediana Edad , Infecciones por Mycobacterium no Tuberculosas/microbiología , Mycobacterium chelonae/aislamiento & purificación , Mycobacterium chelonae/patogenicidad , Mycobacterium fortuitum/aislamiento & purificación , Mycobacterium fortuitum/patogenicidad , Infección de la Herida Quirúrgica/microbiología , Factores de TiempoRESUMEN
BACKGROUND: Mycobacterium chelonae and Mycobacterium fortuitum are the 2 most commonly implicated species of nontuberculous mycobacteria in cases of bacterial keratitis. OBJECTIVES: This article summarizes available data on the in vitro antibacterial activity against M chelonae or M fortuitum of 2 agents-amikacin and clarithromycin-that have been used in the treatment of bacterial keratitis. In addition, the article reviews the in vitro activity of 5 commercially available topical ocular fluoro-quinolones (in order of availability, ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin) that may have potential in the surgical prophylaxis and treatment of keratitis caused by M chelonae or M fortuitum. METHODS: A search of the English-language literature indexed on the MEDLINE, Life Sciences, EMBASE, BIOSIS, and Pharmaprojects databases from 1966 to October 7, 2003, was conducted using the terms Mycobacterium chelonae, Mycobacterium fortuitum, bacterial keratitis, topical antibiotic therapy, ocular infection-mycobacteria, and LASIK infections. Data on the minimum concentrations at which 90% of isolates were inhibited (MIC(90)s) were reviewed and compared. RESULTS: In the literature reviewed, the MIC(90) against M fortuitum was from 1 to 16 microg/mL for amikacin, from =2 to >/=8 microg/mL for clarithromycin, from 0.1 to 1 microg/mL for ciprofloxacin, from 0.5 to 3.13 microg/mL for ofloxacin, and =2 microg/mL for levofloxacin. The results were similar against M chelonae. The fourth-generation fluoroquinolones-gatifloxacin and moxifloxacin-had similar MIC(90)s against M fortuitum (both, 0.2 to 1 microg/mL); however, moxifloxacin had greater activity than gatifloxacin against M chelonae (minimum inhibitory concentration range: moxifloxacin, =1 to 1.6 microg/mL; gatifloxacin, 3.2 to 6.25 microg/mL). CONCLUSIONS: Topical fluoroquinolones may be beneficial for ocular surgical prophylaxis and for the treatment of keratitis caused by M chelonae or M fortuitum. Based on their reported MIC(90)s, none of the antibacterials reviewed had greater in vitro activity than moxifloxacin. In addition, moxifloxacin had greater in vitro activity than gatifloxacin against M chelonae, one of the predominant nontuberculous mycobacterial species involved in bacterial keratitis. Pending the conduct of controlled clinical studies, these findings suggest that moxifloxacin may have utility in the prevention and treatment of atypical mycobacterial keratitis.
Asunto(s)
Antiinfecciosos/uso terapéutico , Fluoroquinolonas/uso terapéutico , Queratitis/tratamiento farmacológico , Infecciones por Mycobacterium no Tuberculosas/tratamiento farmacológico , Mycobacterium chelonae/efectos de los fármacos , Mycobacterium fortuitum/efectos de los fármacos , Administración Tópica , Antiinfecciosos/administración & dosificación , Antiinfecciosos/farmacología , Fluoroquinolonas/administración & dosificación , Fluoroquinolonas/farmacología , Humanos , Queratitis/microbiología , Pruebas de Sensibilidad Microbiana , Mycobacterium chelonae/patogenicidad , Mycobacterium fortuitum/patogenicidadRESUMEN
OBJECTIVES: A series of cases infected with rapidly growing mycobacteria was studied to determine the spectrum of disease, antimicrobial susceptibility, treatment, and outcome. METHODS: The cases identified as infections with rapidly growing mycobacteria in Ramathibodi Hospital from January 1993 to December 1999 were retrospectively studied. RESULTS: Most of the cases had no underlying disease. Only two cases were HIV-infected patients. The presenting clinical features were lymphadenitis (seven cases), skin and/or subcutaneous abscess (seven cases), localized eye infection (four cases), pulmonary infection (one case), and chronic otitis media (one case). Four of seven cases with lymphadenitis had Sweet's syndrome, and one had psoriasis as an associated skin manifestation. Anemia was present in five cases, and improved with treatment of the primary disease. The organisms were Mycobacterium chelonae/abscessus group (17 cases) and Mycobacterium fortuitum group (three cases). Susceptibility patterns of the organisms showed susceptibility to amikacin, netilmicin, and imipenem. M. fortuitum group was susceptible to more antibiotics than M. chelonae/abscessus group. The clinical responses corresponded to the antimicrobial susceptibility. Combinations of two or more drugs were used for the medical treatment. Surgical resection was performed where possible, to reduce the load of the organism, especially in cases with very resistant organisms. CONCLUSIONS: Infections with rapidly growing mycobacteria can occur in apparently normal hosts. The clinical syndrome is variable. The pathology is nonspecific. Clinical responses varied, but seemed to correlate with the in vitro susceptibility result. More studies are needed to enable us to deal with this infection effectively.